Cargando…
Oral Therapy for the Treatment of Transthyretin-Related Amyloid Cardiomyopathy
The care of systemic amyloidosis has improved dramatically due to improved awareness, accurate diagnostic tools, the development of powerful prognostic and companion biomarkers, and a continuous flow of innovative drugs, which translated into the blooming of phase 2/3 interventional studies for ligh...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9788438/ https://www.ncbi.nlm.nih.gov/pubmed/36555787 http://dx.doi.org/10.3390/ijms232416145 |